Headache Medicine 2021, 12(1) p-ISSN 2178-7468, e-ISSN 2763-6178
59
ASAA
DOI: 10.48208/HeadacheMed.2021.12
Headache Medicine
© Copyright 2021
Case Report
Persistent idiopathic facial pain associated with borderline personality
disorder: a case report
Hugo André de Lima Martins
1
Bruna Bastos Mazullo Martins
1
Camilla Cordeiro dos Santos
2
Djanilson Jose Pontes
2
Daniella Araújo de Oliveira
3
Marcelo Moraes Valenca
4,5
1
Unidade do Cérebro, Surubim, Pernambuco, Brazil.
2
Esuda Faculty, Recife, Pernambuco, Brazil.
3
Departmente of Physiotherapy, Universidade Federal e Pernambuco, Recife, PE, Brazil.
4
Neurosurgery Unit, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
5
Unimed Recife, Recife, Pernambuco, Brazil.
Abstract
Introduction
Borderline personality disorder may be associated with persistent facial pain since its relationship with
different pain syndromes has been reported. Persistent idiopathic facial pain is commonly unilateral, pulsa-
ting, burning, or profound and challenging for clinicians. Therefore, excluding underlying organic causes
by appropriate clinical investigation and complementary tests is essential to diagnose this disease.
Objective
This case report aimed to provide evidence of the relationship between idiopathic persistent facial pain
and borderline personality disorder.
Case report
A 24-year-old woman reported severe pain in the left hemiface for ten months, three to six hours per
day, ve days per week. No abnormalities were found in dental and neurological assessments. A psy-
chiatric evaluation was performed, and the patient met the criteria for borderline personality disorder.
Pharmacological treatment consisted of daily lithium carbonate (900 mg) and venlafaxine (150 mg).
Weekly sessions of cognitive-behavioral therapy with emotional regulation and tolerance to stress were
performed. The patient was evaluated every 30 days and showed improved pain intensity and frequency
over six months.
Conclusion
Proper management of borderline personality disorder can modify the evolution of persistent idiopathic
facial pain when both pathologies are comorbidities.
Hugo André de Lima Martins
Rua Antônio Medeiros Sobrinho,
275, Cabaceira, Surubim-PE,
Brasil
hugomt2001@yahoo.com.br
Edited by:
Marcelo Moraes Valença
Keywords:
Cognitive Behavioral Therapy
Facial Pain
Borderline Personality Disorder
Lithium Carbonate
Venlafaxine Hydrochloride
Received: July 4, 2021
Accepted: July 30, 2021
60
ASAA
Martins HAL, Martins BBM, Santos CC, Pontes J, Oliveira DA, Valença MM
Persistent idiopathic facial pain associated with borderline personality disorder: a case report
Introduction
P
ersistent idiopathic facial pain (PIFP) is a chronic disease of
unknown etiology. Patients usually complain of unilateral pain
affecting the maxillary region, usually described as burning, pul-
sating, profound, or painful. However, as described in Figure 1,
PIFP neither meet criteria for neuralgia nor present objective signs of
neurological changes on imaging or clinical examination or dental
causes after a detailed investigation.
1
Furthermore, few controlled
studies demonstrated these patients might present a poor clinical
response to antidepressant use (e.g., amitriptyline and nortriptyline)
and improved quality of life when associated with psychotherapy.
2
Association of PIFP and depression, anxiety symptoms, and poor
quality of life are well documented in previous studies, although only
a few studies about personality traits were performed.
2,3
A. Facial and/or oral pain fullling criteria B and C.
B. Recurring daily for >2 hours/day >3 months.
C. Pain has both of the following characteristics:
1. Poorly localized and not following distribution of peripheral nerve.
2. Dull, aching, or nagging quality.
D. Clinical neurological examination is normal.
E. Dental cause has been excluded by appropriate investigations.
F. Not better accounted for by another ICHD -3 diagnosis.
Figure 1. Persistent idiopathic facial pain diagnostic criteria (ICHD-3)
A set of stable individual characteristics (i.e., specic functioning
patterns) is formed by a set of stable individual characteristics
with a personal manner of perceiving oneself, other people, and
life events.
4
However, a personality disorder might be present
when this pattern is rigid, pervasive, inexible, and maladaptive.
Personality disorders affect approximately 10% of the population,
with borderline personality disorder (BPD) corresponding to half
of this content.
5
Among all personality disorders, BPD is the most related to painful
syndromes.
6
Table 1 shows the
Diagnostic and Statistical Manual
of Mental Disorders
(DSM-5) diagnostic criteria for BPD (ve out of
nine criteria are required for diagnosis). BPD is characterized by
severe changes in cognition, emotion, behavior, and interpersonal
relationships. Self-injurious behaviors are frequent, such as hair
pulling, slapping, throwing on the oor, hitting head on the wall,
cutting, or scratching. Non-lethal attempt methods sometimes
follow suicidal ideation (e.g., excessive medication-taking at once)
or violent methods, such as hanging, jumping from high places,
throwing themselves in front of automobiles at high speed, and
self-harm with knives or rearms.
6-8
Studies observed a 30% prevalence rate of BPD among patients
with chronic pain. Pain scores are higher in patients with chronic
pain and BPD than those patients without BPD.
6
One study
evaluated 777 patients undergoing pain rehabilitation and
observed more pain complaints in those with BPD.
9
In a study
evaluating patients with BPD found more painful syndromes (e.g.,
lumbar pain, temporomandibular joint [TMJ] disorders, and
bromyalgia) in patients with active BPD symptoms than patients
with remission of BPD symptoms.
10
Table 1 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic
criteria for borderline personality disorder
1. Frantic efforts to avoid real or imagined abandonment (Note: Do not
include suicidal or self-mutilating behavior covered in Criterion 5);
2. Pattern of unstable and intense interpersonal relationships characterized by
alternating between extremes of idealization and devaluation;
3. Identity disturbance: markedly and persistently unstable self-image or sense
of self;
4. Impulsivity in at least two areas that are potentially self-damaging (e.g.,
spending, sex, substance abuse, reckless driving, binge eating) (Note: Do not
include suicidal or self-mutilating behavior covered in Criterion 5);
5. Recurrent suicidal behavior, gestures, threats, or self-mutilating behavior;
6. Affective instability due to a marked reactivity of mood (e.g., intense episodic
dysphoria, irritability, or anxiety usually lasting a few hours and only rarely
more than a few days);
7. Chronic feelings of emptiness;
8. Inappropriate, intense anger or difculty controlling anger (e.g., frequent
displays of temper, constant anger, recurrent physical ghts);
9. Transient, stress-related paranoid ideation or severe dissociative symptoms.
Clinical observations showed that patients with BPD are more
intolerant to chronic pain.
11
Brain imaging studies in BPD
demonstrated top-down dysregulation in emotional control
12
inuencing chronic pain signaling.
7,12
Some neural structures in
the fronto-limbic region are also altered in BPD. Studies using
functional magnetic resonance imaging demonstrated increased
amygdala reactivity and reduced activity in the prefrontal cortex
and anterior area of the cingulate gyrus, regions involved in
abnormal pain processing.
9
Therefore, this study aims to report a patient with PIFP and BPD
who did not respond to treatments before BPD diagnosis and
showed good clinical evolution after proper psychotherapeutic
BPD management associated with psychopharmacological
treatment for mood stabilization.
Case report
This study was conducted at the Brain Unity Clinic in Surubim-PE
(Brazil) and approved by the human research ethics committee
(protocol number 464456921.4.000.5640). This case report
concerns a 24-year-old woman with a history of severe pain on
the left side of the face for ten months. She reported diffuse pain
without specic exacerbation points lasting three to six hours, ve
days per week. She denied dental procedures before pain onset
and attended several dental evaluations because she believed it
could be a dental problem. TMJ imaging by magnetic resonance
(MRI) and arthroscopy showed nonspecic changes and did not
elucidate the cause of pain. She was also evaluated and treated
by a neurologist, who did not encounter any abnormalities after
a detailed neurological examination of facial sensitivity. Brain
MRI was also normal. She used daily 50 mg of amitriptyline,
carbamazepine (600 mg), and gabapentin (900 mg) during
previous treatments.
61
ASAA
Martins HAL, Martins BBM, Santos CC, Pontes J, Oliveira DA, Valença MM
Persistent idiopathic facial pain associated with borderline personality disorder: a case report
The patient mentioned two events that negatively impacted her
life. During childhood (ve years old), the rst happened when
she was run over and hospitalized for several days for medical
observation, which psychically affected her. The other event was
her mother's absence during baptism, triggering an intense belief
of rejection, despite becoming aware of this fact several years
later after other people telling her.
In the rst evaluation, the patient complained about severe
mood instability, intense feelings of emptiness, frequent crisis
of unmotivated anger, suicidal ideation, frantic efforts to avoid
abandonment, and severe binge eating as emotional regulation
(i.e., six out of nine criteria used for BPD diagnosis). During a
mental evaluation, the patient was conscious and auto- and
allopsychically oriented, anxious, with mood lability, reduced
attention and concentration, presented hypomnesia for recent
events, organized thinking, and no sensoperceptual alterations.
Pharmacological treatment with lithium carbonate initiated with
300 mg at night, until reaching 900 mg per day, was associated
with venlafaxine (initial dose of 37.5 mg per day and nal dose of
150 mg after 30 days). Serum lithium dosage was 0.7 millimole
per liter during treatment. Weekly sessions of psychotherapy were
also indicated with training elements for emotional regulation and
tolerance to stress.
Furthermore, four inventories were used to quantify mental changes
in a psychiatric evaluation. For Borderline Symptom List 23 (BSL-
23), an inventory with a list of borderline symptoms, the patient
achieved a total score of 44/92 of possible symptoms at initial
evaluation and 29/92 after six months of treatment. For Beck
Depression Inventory (BDI), the score was 32 at initial evaluation
and 13 after six months of treatment. For Beck Anxiety Inventory
(BAI), the score was 22 at initial evaluation and nine after six
months of treatment. Finally, she achieved an initial score of 6/20
in the Subjective Memory Complaints scale (SMCs), decreasing to
2/6 after six months of treatment. The patient was evaluated every
30 days and improved pain intensity and frequency gradually
over six months. Pain intensity was assessed using the eleven-point
(0-10) visual analog scale and improved during this period (from
eight at initial evaluation to two after six months of treatment)
(Figure 2).
Figure 2. Evolution of pain symptoms on visual pain scale.
Discussion
This study reports a patient diagnosed with persistent and refractory
facial pain investigated for personality disorder. Such comorbidity
directly inuences PIFP treatment since it changes the therapeutic
approach by focusing on pharmacological and psychotherapeutic
treatments, most indicated in personality disorders.
7
Pain is a sensory and emotional experience that may become
chronic after six months, leading to loss of function and severe
disability.
3
PIFP is probably the most challenging type of facial
pain for clinical management. A multidisciplinary team approach
helps identify social, environmental, and intrapsychic factors
inuencing patient evolution.
Herein, the patient presented a distorted belief of affective bond
with her mother because her mother did not attend the baptism.
For this reason, the patient developed a trait of insecurity and
frequent fear of being abandoned, which is characteristic of BPD
patients.
7
Existential emptiness reported was probably because
she thought other people were invalidating her suffering, which is
reinforced by lack of ndings in complementary exams.
In the past, PIFP was called psychogenic facial pain. A study
from the United Kingdom evaluated 150 patients with PIFP and
observed that three out of 55 patients excluded were referred
to psychiatric hospital admission, and four patients decided to
search for psychiatric care at another service.
13
As 20% to 25% of
patients admitted to psychiatric hospitals have BPD, it would not be
surprising if some of these patients with PIFP also presented severe
emotional dysregulation. Another study assessing the personality
prole of three patients with PIFP using Cloninger's Temperament
and Character Inventory found common characteristics among
patients (egocentrism, high levels of insecurity, shame, and
harm avoidance), suggesting exaggerated attention to pain and
oneself, which may play a fundamental role in chronicity and
resistance to treatment.
3
Depression is present in more than 80% of patients with BPD.
14
The clinician must identify the correlation between depression
and BPD since treatment with antidepressants alone may not be
effective. Anxiety is also commonly found in patients with BPD.
BPD and anxiety may not only co-occur but also inuence the
therapeutic response of each other.
15
Our patient presented many
depressive and anxiety symptoms at the beginning of treatment
and improved signicantly after six months of follow-up, as shown
by the marked decrease in BDI and BAI scores.
Patients with BPD frequently complain about memory problems
during daily activities, although this nding is not present in
memory tests.
16
The patient of the present study partially improved
subjective memory complaints throughout treatment, as evidenced
by SMC. Memory complaints in patients with BPD are probably
from the negative self-perception of these patients; therefore,
improving affective dysregulation may also improve memory.
62
ASAA
Martins HAL, Martins BBM, Santos CC, Pontes J, Oliveira DA, Valença MM
Persistent idiopathic facial pain associated with borderline personality disorder: a case report
Know about emotional dysregulation is crucial to understand
BPD.
8
The patient described in this study showed severe emotional
instability, crises of unmotivated anger, and binge eating. Many
patients with BPD manifest emotional dysregulation by alcohol
and drug abuse, leading to substance dependence. Other
patients manifest this dysregulation in the sexual area (promiscuity
conditions), food area (binge eating), or pain area (chronic pain).
In this study, the patient manifested characteristics of binge eating
and chronic pain.
The interplay between BPD and pain is complex. For example,
patients with this disorder are insensitive to acute pain, making
supercial skin cuts during self-mutilation episodes. On the other
hand, clinical studies show that these patients are more sensitive
to chronic pain than individuals without personality disorders.
17
Therefore, evaluating borderline traits in patients with PIFP is
essential because patients with BPD symptoms remission present
pain relief and less analgesic use, which are essential for pain
chronication.
9,10
The most important symptom of the studied patient was persistent
suicidal ideation, one of the most notable characteristics of BPD.
This symptom guided lithium (mood stabilizer with high anti-suicide
action) as pharmacological choice
18,19
associated with venlafaxine
(dual-action antidepressant). Moreover, these drugs act in the
serotoninergic pathway by decreasing impulsivity, aggressiveness,
and the risk of suicide.
18
However, lithium must be within the
therapeutic window due to its high lethality rate.
19
Psychotherapy was indicated for cognitive restructuring and
behavioral change since the patient was diagnosed with a
personality disorder. The patient changed her main beliefs
regarding her and the outside world using adequate cognitive and
behavioral techniques as muscle relaxation and diaphragmatic
breathing. Emotion regulation and stress tolerance skills were
also provided, contributing to managing inappropriate anger and
compulsive eating.
The association between pharmacological treatment for main
psychiatric symptoms and psychotherapeutic follow-up probably
improved the patient's facial pain. Thus, this study highlights the
association between BPD and PIFP. Many PIFP cases may remain
unsolved due to the lack of a detailed assessment regarding the
meaning of pain of each patient. Ideally, all patients diagnosed
with PIFP presenting some degree of refractoriness to usual
treatment should be evaluated by a mental health team, increasing
treatment efcacy.
Hugo Andre de Lima Martins
https://orcid.org/0000-0002-5216-2074
Bruna Bastos Mazullo Martins
https://orcid.org/0000-0002-6251-992X
Camilla Cordeiro dos Santos
https://orcid.org/0000-0002-5094-7337
Djanilson Jose Pontes
https://orcid.org/0000-0001-9578-5805
Daniella Araújo de Oliveira
https://orcid.org/0000-0002-6013-978X
Marcelo Moraes Valenca
https://orcid.org/0000-0003-0678-3782
References
1. Headache Classification Committee of the International
Headache Society (IHS) The International Classification of
Headache Disorders, 3rd edition.
Cephalalgia
2018;38(1):1-
211 Doi: 10.1177/0333102417738202
2. Borges RdS, Kraychete DC, Borges ELG and Melo VMd.
Persistent idiopathic facial pain, a diagnosis and treatment
of challenge. Case report.
BrJP
2018;1(3):279-282 Doi:
10.5935/2595-0118.20180053
3. Christofolleti LM, Oliveira MdFV and Siqueira SRDTd.
Personality, coping and atypical facial pain. Case reports.
BrJP
2018;1(1):77-79 Doi: 10.5935/2595-0118.20180016
4. Millon T. Teorias da psicopatologia e personalidade: ensaios e
críticas. 2 ed. Rio de Janeiro: Editora Interamericana; 1979. p.
360.
5. Louzã MR and Cordás TA. Transtornos da Personalidade. 2.ed.
Porto Alegre: Artmed Editora; 2019. p. 216.
6. Sansone RA and Sansone LA. Chronic pain syndromes and
borderline personality.
Innov Clin Neurosci
2012;9(1):10-14
7. Martins H. Is borderline personality disorder the cause of chronic
headache?
Av em Med
2021;1(1):75-76 Doi: 10.52329/
AvanMed.15
8. Martins H, Martins B, Martins B, Ribas V and Santos A.
Borderline and Antisocial Personality Disorders in the Bible.
J
Psychol Psychother Res
2021;8(1):11-21 Doi: 10.12974/2313-
1047.2021.08.2
9. Tragesser SL, Bruns D and Disorbio JM. Borderline personality
disorder features and pain: the mediating role of negative affect
in a pain patient sample.
Clin J Pain
2010;26(4):348-353 Doi:
10.1097/AJP.0b013e3181cd1710
10. Frankenburg FR and Zanarini MC. The association between
borderline personality disorder and chronic medical illnesses,
poor health-related lifestyle choices, and costly forms of health
care utilization.
J Clin Psychiatry
2004;65(12):1660-1665 Doi:
10.4088/jcp.v65n1211
11. Harper RG. Personality-guided therapy in behavioral medicine.
Personality-guided therapy in behavioral medicine. Washington,
DC, US: American Psychological Association; 2004. p. 359.
12. Perez-Rodriguez MM, Bulbena-Cabré A, Bassir Nia A, Zipursky
G, Goodman M and New AS. The Neurobiology of Borderline
Personality Disorder.
Psychiatr Clin North Am
2018;41(4):633-
650 Doi: 10.1016/j.psc.2018.07.012
13. Feinmann C. Psychogenic facial pain: Presentation and
treatment.
J Psychosomatic
1983;27(5):403-410 Doi:
10.1016/0022-3999(83)90076-4
14. Beatson J and Rao S. Depression and borderline personality
disorder.
Med J of Australia
2012;197(11):620-621 Doi:
10.5694/mja12.11646
15. Bulbena-Cabre A, Perez-Rodriguez MM, Porges S, Bulbena
A and Goodman M. Understanding Anxiety in Borderline
Personality Disorder.
Curr Treat Options Psych
2017;4(2):281-
294 Doi: 10.1007/s40501-017-0122-0
16. Beblo T, Mensebach C, Wingenfeld K, Rullkoetter N, Schlosser
63
ASAA
Martins HAL, Martins BBM, Santos CC, Pontes J, Oliveira DA, Valença MM
Persistent idiopathic facial pain associated with borderline personality disorder: a case report
N and Driessen M. Subjective memory complaints and memory
performance in patients with borderline personality disorder.
BMC Psychiatry
2014;14(1): Doi: 10.1186/s12888-014-0255-2
17. Sansone RA and Sansone LA. Borderline personality and the
pain paradox.
Psychiatry (Edgmont)
2007;4(4):40-46
18. Berghöfer A. Lithium and suicide.
Bmj
2013;347(f4449) Doi:
10.1136/bmj.f4449
19. Benard V, Vaiva G, Masson M and Geoffroy PA. Lithium
and suicide prevention in bipolar disorder.
Encephale
2016;42(3):234-241 Doi: 10.1016/j.encep.2016.02.006